首页> 外文期刊>Neuroscience Letters: An International Multidisciplinary Journal Devoted to the Rapid Publication of Basic Research in the Brain Sciences >Attenuating phosphorylation of p38 MAPK in the activated microglia: A new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats.
【24h】

Attenuating phosphorylation of p38 MAPK in the activated microglia: A new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats.

机译:减轻激活的小胶质细胞中p38 MAPK的磷酸化:鞘内利多卡因逆转大鼠慢性收缩损伤后的触觉异常性疼痛的新机制。

获取原文
获取原文并翻译 | 示例
           

摘要

Increasing evidences approve the long-term analgesia effects of intrathecal lidocaine in patients with chronic pain and in animal peripheral nerve injury models, but the underlying mechanism remains elusive. Previous evidences suggest that the activation of the p38 MAPK signaling pathway in hyperactive microglia in the dorsal horn of spinal cord involves in nerve injury-induced neuropathic pain. In this study, we demonstrate that attenuating phosphorylation of p38 MAPK in the activated microglia of spinal cord, at least partly, is the mechanism of intrathecal lidocaine reversing established tactile allodynia in chronic constriction injury model of rats. This finding not only provides a new insight into the mechanisms underlying long-term therapeutic effects of lidocaine on neuropathic pain, but also reveals one more specific drug target for analgesia.
机译:越来越多的证据支持鞘内注射利多卡因对慢性疼痛患者和动物周围神经损伤模型的长期镇痛作用,但其潜在机制尚不清楚。先前的证据表明,脊髓背角多动小胶质细胞中p38 MAPK信号通路的激活涉及神经损伤引起的神经性疼痛。在这项研究中,我们证明,在脊髓的活化小胶质细胞中p38 MAPK的磷酸化减弱,至少部分是鞘内注射利多卡因逆转大鼠慢性收缩性损伤模型中已建立的触觉异常性疼痛的机制。这一发现不仅提供了对利多卡因对神经性疼痛的长期治疗作用基础的机制的新见解,而且还揭示了镇痛的一种更具体的药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号